Lipoprotein-Associated Phospholipase A2Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus
Open Access
- 10 April 2014
- journal article
- research article
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2014, 1-6
Abstract
Objective. Lipoprotein-associated phospholipase A2(Lp-PLA2) is extensively expressed by advanced atherosclerotic lesions and may play a role in plaque instability. We selected a group of elderly subjects that underwent transcatheter aortic valve implantation (TAVI) or balloon angioplasty (BA) and separated them into two groups, diabetic and nondiabetic, to compare the level of Lp-PLA2mass between them.Methods. 44 patients agedyears with symptomatic severe aortic valve stenosis underwent TAVI () or BA (). 21 subjects had confirmed type 2 diabetes mellitus. Lp-PLA2mass was measured using an enzyme-linked immunosorbent assay kit (USCN Life Science, China) before and 3 days after the procedure.Results. Lp-PLA2mass was significantly elevated in this population ( ng/mL before TAVI; ng/mL before BA) and further increased after TAVI ( ng/mL,) or BA ( ng/mL,). Lp-PLA2mass was significantly increased on the diabetic group before these interventions.Conclusion.Lp-PLA2may be a novel biomarker for the presence of rupture-prone atherosclerotic lesions in elderly patients. Levels of Lp-PLA2in diabetic patients may accompany the higher amount of small dense LDL particles seen in these subjects.
Keywords
Funding Information
- IGA MH CR (NT/12287-5, PRVOUK P37/12)
This publication has 26 references indexed in Scilit:
- Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve ImplantationPLOS ONE, 2012
- Phospholipase A2 enzymes in metabolic and cardiovascular diseasesCurrent Opinion in Lipidology, 2012
- Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular riskEPMA Journal, 2011
- Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery diseaseJournal of Internal Medicine, 2010
- Lipoprotein-associated phospholipase A2 and atherosclerosisCurrent Opinion in Lipidology, 2009
- Lipoprotein-Associated Phospholipase A2 and Risk of StrokeThe American Journal of Cardiology, 2008
- Association of Lipoprotein-Associated Phospholipase A 2 Mass and Activity With Calcified Coronary Plaque in Young AdultsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Definition of Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular diseaseCurrent Opinion in Lipidology, 2003
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageNature, 2000